Reduction in tumor size was a consequence of decreased proliferation and increased apoptosis of tumor cells, as determined by in situ immunostaining of tumor sections with the proliferation marker Ki67 and the apoptotic assay Terminal Uridine Nick-End Labeling (TUNEL), respectively (Fig. 6C, D). This evidence concerns the gene MKI67 and neoplasm.